SR9009, also known as Stenabolic, is a SARM that was developed at the Scripps Research Institute. It is a PPAR alpha modifier very similar GW-501516. It binds to the Rev-erbα protein, which influences lipid and glucose metabolism in the liver and the creation of fat-storing cells.
Stenabolic has been found to increase mitochondria, the powerhouses of your cells. Once mice were given Stenabolic, they were able to run for 50% longer than non-treated mice. It has also been found to aid weight loss.
This material is sold for use in laboratory research only. Terms of sale apply. Not for human consumption, nor for medical, veterinary or domestic use. Please familiarize yourself with our DISCLAIMER before ordering.
Stenabolic SR-9009 – Solution, 600mg (20mg/mL)
|Application||A potent agonist of Rev-ErbA|
|Molar Mass||437.94 g/mol|
|IUPAC Name||ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate|
|Synonyms||SR9009, SR-9009, SR 9009, Stenabolic|
|Solubility||Soluble in Ethanol, DMSO. Slow degradation in PEG400|
|Organoleptic Profile||Clear Liquid|
|Physical Form||Solution in PEG-400 , Ethanol|
|Terms||This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.|